Hormone replacement therapy and other potential treatments for dementias

Endocrinol Metab Clin North Am. 1997 Jun;26(2):329-45. doi: 10.1016/s0889-8529(05)70250-4.

Abstract

The past decade has seen a substantial increase in the number of individuals affected by dementia. Dementia places a tremendous personal and economic burden on millions of patients and caregivers annually. Consequently, many scientists have been searching for a treatment for dementia to avoid the imminent public health crisis that will occur if this trend continues. Primary and secondary prevention studies, as well as animal research, demonstrate the potential for hormone replacement therapy (HRT) as an efficacious treatment for dementia. Recently, the Women's Health Initiative-Memory Study began the first randomized, longterm clinical trial to test the hypothesized role of HRT at the onset and in the progression of dementia in women. Researchers also are investigating the potential of other treatments for dementias, such as nonsteroidal anti-inflammatory drugs and free radical scavengers.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease / drug therapy
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Clinical Trials as Topic
  • Dementia / drug therapy*
  • Dementia / prevention & control
  • Dementia, Vascular / drug therapy
  • Estrogen Replacement Therapy*
  • Female
  • Humans
  • Memory Disorders / drug therapy
  • Risk Factors

Substances

  • Anti-Inflammatory Agents, Non-Steroidal